INR 16.97
(-0.06%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 8.44 Million | -6.97 Million | 3.38 Million | -2.84 Million | -10.97 Million | 4.8 Million |
Net Income | 10.17 Million | 6.52 Million | -9.02 Million | -12.88 Million | -7.53 Million | -6.03 Million |
Depreciation & Amortization | 1.93 Million | 1.03 Million | 4.2 Million | 4.56 Million | 4.56 Million | 4.77 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -4.34 Million | -15.57 Million | 9.3 Million | 10.78 Million | -6.87 Million | 7.73 Million |
Other non-cash items | 638 Thousand | 1.03 Million | -1.09 Million | -5.3 Million | -1.13 Million | -1.67 Million |
Investing Cash Flow | -9.18 Million | 123 Thousand | 883 Thousand | 325 Thousand | 11.93 Million | -5.15 Million |
Investments in PPE | -9.22 Million | - | - | -26 Thousand | - | -458.87 Thousand |
Acquisitions | - | - | - | -123 Thousand | - | - |
Investment purchases | - | - | -45.5 Million | -3 Million | - | - |
Sales/Maturities of investments | - | - | 45.56 Million | 3.12 Million | 11.78 Million | - |
Other Investing Activities | 38 Thousand | 123 Thousand | 819 Thousand | 351 Thousand | 151.16 Thousand | -4.69 Million |
Financing Cash Flow | 2.12 Million | 4.26 Million | -3.35 Million | 4.18 Million | -603.17 Thousand | -468.32 Thousand |
Debt repayment | -2.8 Million | -4.56 Million | -3.17 Million | -4.2 Million | - | -468.32 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2.24 Million | 4.26 Million | -3.35 Million | 4.18 Million | -603.17 Thousand | - |
Accounts receivables | 5.74 Million | -6.09 Million | -1.86 Million | 3.47 Million | -4.49 Million | 3.82 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -1.67 Million | -9.47 Million | 11.16 Million | 7.31 Million | -2.38 Million | 3.91 Million |
Cash at beginning of period | 1.37 Million | 4.06 Million | 3.15 Million | 1.48 Million | 1.12 Million | 1.94 Million |
Cash at end of period | 2.76 Million | 1.37 Million | 4.06 Million | 3.15 Million | 1.48 Million | 1.12 Million |
Capital Expenditure | -9.22 Million | - | - | -26 Thousand | - | -458.87 Thousand |
Effect of forex changes on cash | - | -100 Thousand | -1000.00 | 43.00 | - | - |
Net cash flow / Change in cash | 1.39 Million | -2.69 Million | 911 Thousand | 1.66 Million | 357.93 Thousand | -823.64 Thousand |
Free Cash Flow | -773 Thousand | -6.97 Million | 3.38 Million | -2.86 Million | -10.97 Million | 4.34 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -6.29 Million | -3.37 Million | 10.17 Million | 948 Thousand | 11.98 Million | 1.09 Million |
Depreciation & Amortization | - | - | 1.93 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -4.34 Million | - | - | - |
Other non-cash items | 6.29 Million | 3.37 Million | 638 Thousand | -948 Thousand | -11.98 Million | -1.09 Million |
Investing Cash Flow | - | - | -9.18 Million | - | - | - |
Investments in PPE | - | - | -9.22 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 38 Thousand | - | - | - |
Financing Cash Flow | - | - | 2.12 Million | - | - | - |
Debt repayment | - | - | -2.8 Million | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -2.24 Million | - | - | - |
Accounts receivables | - | - | 5.74 Million | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | -1.67 Million | - | - | - |
Cash at beginning of period | - | - | 1.37 Million | - | - | - |
Cash at end of period | - | - | 2.76 Million | - | - | - |
Capital Expenditure | - | - | -9.22 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 1.39 Million | - | - | - |
Free Cash Flow | - | - | -773 Thousand | - | - | - |
688611
SHK
6651
002989
4848
BIOGEN